HR 1839
Combating Illicit Xylazine Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Combating Illicit Xylazine Act, aims to address the growing public health crisis related to xylazine, a sedative often mixed with fentanyl. It criminalizes the manufacturing, distribution, and possession with intent to distribute xylazine for human use, treating it similarly to schedule III substances. The bill also directs the DEA to coordinate with the FDA to track xylazine’s prevalence and supply chains, and requires regular reports to Congress on its impact and potential scheduling changes. Furthermore, it expands penalties for xylazine distribution and adds xylazine to the list of controlled substances tracked by the DEA.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Abigail Davis Spanberger
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.